Neuren Pharmaceuticals Limited logo

Neuren Pharmaceuticals Limited (NEU)

Market Open
CXA CXA
- Market Cap
14.45 P/E Ratio
0.47% Div Yield
63,494 Volume
0 Eps
Want to track NEU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 56 days

Summary

NEU trading today higher, an increase of 3.25% from yesterday's close, completing a monthly increase of 0.82%. Over the past 12 months, NEU stock gained 37.38%.
NEU pays dividends to its shareholders, with the most recent payment made on Oct 01, 2025. The next announced payment will be in In 3 weeks on Jan 02, 2026 for a total of A$3.
The last earnings report, released on Oct 22, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 02, 2026.
Neuren Pharmaceuticals Limited has completed 7 stock splits, with the recent split occurring on Jul 01, 2002.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).
NewMarket Corporation (NEU) Q3 2025 Earnings Call Prepared Remarks Transcript

NewMarket Corporation (NEU) Q3 2025 Earnings Call Prepared Remarks Transcript

NewMarket Corporation ( NEU ) Q3 2025 Earnings Call October 31, 2025 3:00 PM EDT Company Participants Timothy Fitzgerald - VP & CFO Presentation Operator Good day, everyone, and welcome to the NewMarket Corporation conference call and webcast to review third quarter 2025 financial results. [Operator Instructions].

Seekingalpha | 1 month ago
NewMarket Corporation (NEU) Q2 2025 Earnings Call Transcript

NewMarket Corporation (NEU) Q2 2025 Earnings Call Transcript

NewMarket Corporation (NYSE:NEU ) Q2 2025 Earnings Call July 31, 2025 3:00 PM ET Company Participants Timothy K. Fitzgerald - VP & CFO Operator Good day, everyone, and welcome to the NewMarket Corporation conference call and webcast to review second quarter 2025 financial results.

Seekingalpha | 4 months ago
NewMarket Corporation (NEU) Q1 2025 Earnings Call Transcript

NewMarket Corporation (NEU) Q1 2025 Earnings Call Transcript

NewMarket Corporation (NYSE:NEU ) Q1 2025 Earnings Conference Call April 24, 2025 3:00 PM ET Company Participants Timothy Fitzgerald - Vice President & Chief Financial Officer Conference Call Participants Operator Greetings and welcome to today's NewMarket Corporation Scheduled Conference Call and Webcast to review First Quarter 2025 Financial Results. At this time, all participants are on a listen-only mode.

Seekingalpha | 7 months ago

Neuren Pharmaceuticals Limited (NEU) FAQ

On which exchange is it traded?

Neuren Pharmaceuticals Limited is listed on NYSE.

What is its stock symbol?

The ticker symbol is NEU.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.47%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 02, 2026.

Has Neuren Pharmaceuticals Limited ever had a stock split?

Neuren Pharmaceuticals Limited had 7 splits and the recent split was on Jul 01, 2002.

Neuren Pharmaceuticals Limited Profile

Air Freight & Logistics Industry
Industrials Sector
Thomas E. Gottwald CEO
CXA Exchange
US6515871076 ISIN
US Country
2,060 Employees
15 Dec 2025 Last Dividend
1 Jul 2002 Last Split
6 Aug 1985 IPO Date

Overview

NewMarket Corporation is a company rooted in innovation and service since its inception in 1887. Headquartered in Richmond, Virginia, it has carved a niche for itself in the petroleum additives market through its various subsidiaries. With operations spanning across North America, Latin America, Asia Pacific, Europe, the Middle East, and Africa, including India, the company is a global leader in its field. NewMarket Corporation is committed to manufacturing and selling high-quality petroleum additives, coupled with offering services in marketing antiknock compounds and contracted manufacturing. It also owns and manages real property in Virginia, showcasing its versatility and breadth in operations.

Products and Services

NewMarket Corporation's offerings are diverse and pivotal to the performance and efficiency of vehicles and industrial machinery. The company's product line is meticulously designed to meet the rigorous demands of modern technology and environmental standards.

  • Lubricant Additives: Developed for vehicle and industrial applications, these additives are essential for engine oils, transmission fluids, powertrain and hydraulic systems, gear oils, hydraulic oils, and turbine oils, ensuring smooth operation of metal-to-metal moving parts.
  • Engine Oil Additives: Crafted for passenger cars, motorcycles, heavy-duty commercial equipment, locomotives, and marine engines. These additives play a critical role in extending the life and enhancing the performance of engines across various platforms.
  • Driveline Additives: Focused on improving the quality of transmission fluids, axle fluids, and off-road powertrain fluids. These additives are key to ensuring the reliability and efficiency of various driveline components.
  • Industrial Additives: Designed for industrial applications including hydraulic fluids, grease, and industrial gear fluids. These additives are tailored to meet the specialized needs of industrial machinery and equipment.
  • Fuel Additives: Aimed at enhancing oil refining processes and the performance of gasoline, diesel, biofuels, and other fuels. NewMarket Corporation’s fuel additives are pivotal in optimizing fuel efficiency and environmental compliance for a wide spectrum of users, including industry, government, OEMs, and individual customers.
  • Antiknock Compounds and Contracted Manufacturing and Services: Beyond its traditional product range, NewMarket Corporation also excels in the marketing of antiknock compounds and provides contracted manufacturing and services, leveraging its extensive industry knowledge and manufacturing capabilities.

Contact Information

Address: 330 South Fourth Street
Phone: 804 788 5000